NeuroRX on the cusp of releasing a life-saving COVID-19 treatment
"The DNA of our company is to go after lost causes with known molecules,” NeuroRX CEO Prof. Jonathan Javitt told the ‘Post.’
Ichilov Medical team at the coronavirus unit, in the Ichilov hospital, Tel Aviv, Israel, July 28, 2020.(photo credit: YOSSI ALONI/FLASH90)ByHAGAY HACOHEN
